Evidence for a Common, Saturable, Triglyceride Removal Mechanism for Chylomicrons and Very Low Density Lipoproteins in Man
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Hypertriglyceridemic subjects were fed diets in which dietary fat calories were held constant, but carbohydrate calories were varied. Three subjects with fasting chylomicronemia (Type V) were given less carbohydrate and four subjects without fasting chylomicronemia (Type IV) were fed diets with more calories as carbohydrate. The restricted carbohydrate intake led to disappearance of chylomicronemia in those subjects who had chylomicronemia on a normal diet (Type V to IV). In those subjects without chylomicronemia, chylomicronemia appeared in response to increased carbohydrate intake (Type IV to V). Thus chylomicron concentrations in plasma were altered even though fat intake and presumably chylomicron input into plasma was kept constant. These findings provide evidence for saturation of chylomicron removal mechanisms by alteration of endogenous triglyceride-rich lipoprotein concentrations. They suggest that chylomicrons compete with very low density lipoproteins for similar removal mechanisms. The relationship between endogenous triglyceride concentration and the lipolytic activity in plasma following heparin was then evaluated with the use of long-term heparin infusions to release and maintain lipolytic activity in the circulation. 10 subjects were placed on fatfree diets to remove circulating dietary fat. The plasma lipolytic rate during the heparin infusion was measured consecutively on different days in individuals whose triglyceride concentrations were varied by either increasing or decreasing calories. The lipolytic rate was curvilinearly related to the plasma triglyceride concentrations. This curvilinear relationship followed Michaelis-Menton saturation kinetics over a wide range of triglyceride concentrations on fat-free, high-carbohydrate diets, in multiple studies in a group of individuals. These studies suggest that endogenous and exogenous triglyceride compete for a common, saturable, plasma triglyceride removal system related to lipoprotein lipase.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In patients with severe or very severe triglyceride levels (Ն1000 mg/dl), the LpL removal system is saturated (74).”
From Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline (2012) · cites this paper as [74]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Factors that reduce VLDL clearance can raise triglyceride concentrations in those with high baseline levels (eg, usually Ͼ500 mg/dL, because of the competition of VLDL and chylomicrons for a common saturable removal mechanism).97”
From Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association (2011) · cites this paper as [97]
Experimental — accuracy not yet measuredIn the citing paper
“In addition, chylomicrons compete with endogenous VLDL for the action of LPL [20].”
From Dyslipidemia in obesity: Mechanisms and potential targets (2013) · cites this paper as [20]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
Fredrickson, D. S., Levy, R. I., & Lees, R. S. (1967) · New England Journal of Medicine · doi:10.1056/nejm196701052760107 · Cited by 1,910
Electrophoretic separation of plasma lipoproteins in agarose gel
Noble, R. P. (1968) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42680-x · Cited by 1,307
Classification of Hyperlipidaemias and Hyperlipoproteinaemias ,
(1972) · Standard Methods of Clinical Chemistry · doi:10.1016/b978-0-12-609107-6.50016-7 · Cited by 820
Editorial: A System for Phenotyping Hyperlipoproteinemia
FREDRICKSON, D. S., & LEES, R. S. (1965) · Circulation · doi:10.1161/01.cir.31.3.321 · Cited by 507
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
Fredrickson, D. S., Levy, R. I., & Lees, R. S. (1967) · New England Journal of Medicine · doi:10.1056/nejm196701122760206 · Cited by 499
Lipolytic activity of post-heparin plasma in hyperglyceridemia
Fredrickson, D. S., Ono, K., & Davis, L. L. (1963) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40361-x · Cited by 370
Havel, R. J., Kane, J. P., Balasse, E. O., Segel, N., & Basso, L. V. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106422 · Cited by 336
The Metabolic Basis of Inherited Disease
Martin, D. B. (1967) · Archives of Internal Medicine · doi:10.1001/archinte.1967.00300020128027 · Cited by 320
Classification of Hyperlipidemias and Hyperlipoproteinemias
(1972) · Circulation · doi:10.1161/01.cir.45.2.501 · Cited by 257
Kinetics of triglyceride turnover of very low density lipoproteins of human plasma
Reaven, G. M., Hill, D. B., Gross, R. C., & Farquhar, J. W. (1965) · Journal of Clinical Investigation · doi:10.1172/jci105290 · Cited by 221
Research works printed but not linked: 2
- [10]10. Boberg, J. 1971. Mechanisms of hypertriglyceridemia in man. Thesis. Acta Universitatis Upsaliensis, Uppsala, Sweden.
- [19]19. Snedecor, G. W., and W. G. Cochran. 1967. Statistical Methods. The Iowa State University Press, Ames. 6th edition. 456.
Cited by
Items 201–300 of 483
Impact of postprandial variation in triglyceridemia on low-density lipoprotein particle size
Blackburn, P., Côté, M., Lamarche, B., Couillard, C., Pascot, A., Tremblay, A., Bergeron, J., Lemieux, I., & Després, J. (2003) · Metabolism · doi:10.1016/s0026-0495(03)00315-9 · Cited by 52
Erkelens, D. W., Brunzell, J. D., & Bierman, E. L. (1979) · Metabolism · doi:10.1016/0026-0495(79)90188-4 · Cited by 45
Self-citationThe effects of diuretics and adrenergic-blocking agents on plasma lipids.
Jj, R., & Jd, B. (1986) · PubMed Central · Cited by 45
Redgrave, T. G., & Martin, G. (1977) · Atherosclerosis · doi:10.1016/0021-9150(77)90200-3 · Cited by 45
Current Diagnosis and Management of Primary Chylomicronemia
Okazaki, H., Gotoda, T., Ogura, M., Ishibashi, S., Inagaki, K., Daida, H., Hayashi, T., Hori, M., Masuda, D., Matsuki, K., et al. (2021) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv17054 · Cited by 48
Higgins, V., Asgari, S., Hamilton, J. K., Wolska, A. T., Remaley, A. T., Hartmann, B., Holst, J. J., & Adeli, K. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz261 · Cited by 50
CHAN, D. C., BARRETT, P. H. R., & WATTS, G. F. (2004) · Clinical Science · doi:10.1042/cs20040109 · Cited by 44
Catabolism of chylomicron triacylglycerol and cholesteryl ester in genetically obese rats
Redgrave, T. G. (1977) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41602-5 · Cited by 44
Lithell, H., Boberg, J., Hellsing, K., Lundqvist, G., & Vessby, B. O. (1978) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1978.tb00814.x · Cited by 44
Platelet kinetic studies in patients with hyperlipoproteinemia: effects of clofibrate therapy.
Harker, L. A., & Hazzard, W. R. (1979) · Circulation · doi:10.1161/01.cir.60.3.492 · Cited by 44
Self-citationTriglyceride-rich Lipoproteins and Atherosclerosis, from Fast to Feast
Steiner, G. A. (1993) · Annals of Medicine · doi:10.3109/07853899309147307 · Cited by 48
Marcoux, C., Hopkins, P. N., Wang, T., Leary, E. T., Nakajima, K., Davignon, J., & Cohn, J. S. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33455-6 · Cited by 43
Padilla, N., Maraninchi, M., Béliard, S., Berthet, B., Nogueira, J.-P., Wolff, E., Nicolay, A., Bégu, A., Dubois, N., Grangeot, R., et al. (2014) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.114.303849 · Cited by 43
Sustained, Low-Intensity Exercise Achieved by a Dynamic Feeding System Decreases Body Fat in Ponies
de Laat, M. A., Hampson, B. A., Sillence, M. N., & Pollitt, C. C. (2016) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.14577 · Cited by 47
“This curvilinear relationship is consistent with the potential for saturable triglyceride removal processes at the extremes of adiposity.(29) Triglyceride concentration was not altered by either the stationary or dynamic feeder (Fig 3B).”
ResultCarbohydrates and Dietary Fiber
Suter, P. M. (2005) · Handbook of experimental pharmacology · doi:10.1007/3-540-27661-0_8 · Cited by 55
“The latter is also associated with a decreased catabolism of triglyceride-rich lipoproteins TRL, resulting in prolonged lipemia (Brunzell et al. 1973).”
BackgroundConnelly, P. W., Maguire, G. F., Vezina, C., Hegele, R. A., & Kuksis, A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32029-x · Cited by 43
Haffner, S. M., Foster, D. M., Kushwaha, R. S., & Hazzard, W. R. (1984) · Diabetologia · doi:10.1007/bf00266035 · Cited by 43
“It has been postulated that a similar abnormality exists in the removal of triglyceride in chylomicrons, and their accumulation results from competition between chylomicron and VLDL triglyceride in a common, saturable lipolytic system mediated by lipoprotein lipase [5], an insulin-dependent enzyme [6].”
Self-citationThe effect of n−3 fatty acids on low density lipoprotein subfractions
Griffin, B. A. (2001) · Lipids · doi:10.1007/s11745-001-0688-6 · Cited by 50
“Both of these lipoproteins share a common saturable pathway for the hydrolysis of their TAG in the circulation via the endothelial lipase lipoprotein lipase (LPL) ( 23 ).”
BackgroundMaraki, M. I., Magkos, F., Christodoulou, N., Aggelopoulou, N., Skenderi, K., Panagiotakos, D. B., Kavouras, S. A., & Sidossis, L. S. (2009) · Clinical Nutrition · doi:10.1016/j.clnu.2009.10.007 · Cited by 48
Couillard, C., Bergeron, N., Pascot, A., Alméras, N., Bergeron, J., Tremblay, A., Prud’homme, D., & Després, J. (2002) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.2.311 · Cited by 49
“On their entry into the circulation, both newly synthesized and endogenous TRLs have been shown to compete for LPL to be hydrolyzed ( 43 ); thus, the increased number of TRL particles in the fasting state could contribute to delaying the clearance of both apo B-48 and apo B-100 TRLs during the postprandial period, as…”
BackgroundChylomicron and apoB48 metabolism in the JCR:LA corpulent rat, a model for the metabolic syndrome
Mangat, R., Su, J. W., Scott, P. G., Russell, J. C., Vine, D. F., & Proctor, S. D. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350477 · Cited by 41
Fatal hyperlipaemia in a case of metastatic breast cancer treated by tamoxifen
Noguchi, M., Taniya, T., Tajiri, K., Miwa, K., Miyazaki, I., Koshino, H., Mabuchi, H., & Nonomura, A. (1987) · British journal of surgery · doi:10.1002/bjs.1800740714 · Cited by 39
UTILIZATION OF FAT EMULSION DURING TOTAL PARENTERAL NUTRITION IN CHILDREN
Forget, P. P., Fernandes, J., & Begemann, P. H. (1975) · Acta Paediatrica · doi:10.1111/j.1651-2227.1975.tb03851.x · Cited by 39
Role of the Gut in Diabetic Dyslipidemia
Stahel, P., Xiao, C., Nahmias, A., & Lewis, G. F. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00116 · Cited by 37
“(5) Antagonism of sodium-glucose cotransporter-1 (SGLT1) is in development as a diabetes therapy to attenuate glucose absorption which may modify CM”
BackgroundA Model of NEFA Dynamics with Focus on the Postprandial State
Jelic, K., Hallgreen, C. E., & Colding‐Jørgensen, M. (2009) · Annals of Biomedical Engineering · doi:10.1007/s10439-009-9738-6 · Cited by 40
Poapst, M. E., Uffelman, K. D., & Steiner, G. A. (1987) · Atherosclerosis · doi:10.1016/0021-9150(87)90009-8 · Cited by 38
Mero, N., Suurinkeroinen, L., Syvänne, M., Knudsen, P., Yki‐Järvinen, H., & Taskinen, M. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33412-x · Cited by 38
“It is widely recognized that chylomi-crons and VLDL particles compete for the same catabolic processes 1 ) lipolysis by LPL and 2 ) receptor-mediated uptake in the liver (36, 37).”
Dhindsa, S., Sharma, A., Al-Khazaali, A., Sitaula, S., Nadella, S., McKee, A. M., Albert, S. G., Bourey, R. E., & Dandona, P. (2019) · Journal of the Endocrine Society · doi:10.1210/jendso/bvz019 · Cited by 37
Leung, N. M., Naples, M., Uffelman, K. D., Szeto, L., Adeli, K., & Lewis, G. F. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.02.005 · Cited by 38
Tomonobu, K., Hase, T., & Tokimitsu, I. (2006) · Nutrition · doi:10.1016/j.nut.2005.04.016 · Cited by 41
Rodríguez-Villar, C., Manzanares, J. M., Casals, E., Pérez-Heras, A., Zambón, D., Gomis, R., & Ros, E. (2000) · Metabolism · doi:10.1053/meta.2000.18573 · Cited by 43
Clearance of artificial triacylglycerol particles.
Olivecrona, G., & Olivecrona, T. (1998) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-199803000-00002 · Cited by 46
Weintraub, M. S., Eisenberg, S., & Breslow, J. L. (1989) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1989.tb00263.x · Cited by 38
King, A. J., Segreti, J. A., Larson, K. J., Souers, A. J., Kym, P. R., Reilly, R. M., Collins, C. A., Voorbach, M. J., Zhao, G., Mittelstadt, S. W., et al. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.03.056 · Cited by 38
“Delayed clearance of intestinally derived lipoproteins has been documented in insulin resistant states; likely the result of competition with VLDL for removal pathways (Brunzell et al., 1973), and reductions in lipoprotein lipase activity (Haffner et al., 1984).”
BackgroundTesaglitazar, a dual PPARα/γ agonist, ameliorates glucose and lipid intolerance in obese Zucker rats
Oakes, N. D., Thalén, P., Hultstrand, T., Jacinto, S. M., Camejo, G., Wallin, B., & Ljung, B. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00252.2005 · Cited by 37
“1) because chylomicrons and VLDL compete for a common lipolytic clearance process (7, 23).”
BackgroundYu, H., Markowitz, R. A., de Ferranti, S. D., Neufeld, E. J., Farrow, G., Bernstein, H. H., & Rifai, N. (2000) · Clinical Biochemistry · doi:10.1016/s0009-9120(00)00055-2 · Cited by 36
Zheng, C., Ikewaki, K., Walsh, B. W., & Sacks, F. M. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m500528-jlr200 · Cited by 38
“(18) and Brunzell and colleagues (36) that intestinal and hepatic TRLs may compete for a common, saturable metabolic pathway postprandially.”
BackgroundPostprandial lipemia and coronary risk
Patsch, W., Esterbauer, H., Föger, B., & Patsch, J. R. (2000) · Current Atherosclerosis Reports · doi:10.1007/s11883-000-0025-0 · Cited by 41
Hypertriglyceridaemia in extremely preterm infants receiving parenteral lipid emulsions
Sinclair, R., Schindler, T., Lui, K., & Bolisetty, S. (2018) · BMC Pediatrics · doi:10.1186/s12887-018-1325-2 · Cited by 35
Verseijden, C., Meijssen, S., van Dijk, H., Jansen, H., & Cabezas, M. C. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300201-jlr200 · Cited by 36
“It has been suggested that chylomicrons compete efficiently with VLDL for the same lipolytic pathway (46), which leads to accumulation of postprandial VLDL (47).”
BackgroundScarsella, C., & Després, J. (2003) · Cadernos de Saúde Pública · doi:10.1590/s0102-311x2003000700002 · Cited by 67
“Estudios adicionales, han sugerido que esto es consecuencia de una sobreproducción hepática de lipoproteínas ricas en triglicéridos, las cuales compiten con las partículas de quilomicrones por su hidrólisis llevada a cabo por la lipasa lipoproteica (Brunzell et al., 1973).”
BackgroundFat elimination in chronic hepatic failure: long-chain vs medium-chain triglycerides
Druml, W., Fischer, M., Pidlich, J., & Lenz, K. (1995) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/61.4.812 · Cited by 35
Clearance of lipoprotein remnant particles in adipose tissue and muscle in humans
Karpe, F., Humphreys, S. M., Samra, J. S., Summers, L. K. M., & Frayn, K. N. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34947-6 · Cited by 39
“The two apoB-containing lipoprotein species share the same lipolytic pathway, but the chylomicrons seem to be the favored substrate for LPL (1-3), resulting in accumulation of apoB-100 in the TRL fraction in the postprandial state (4-6).”
BackgroundInfluentialInfluence of Dietary Fatty Acids on the Atherogenic Lipoprotein Phenotype
Griffin, B. A., & Zampelas, A. (1995) · Nutrition Research Reviews · doi:10.1079/nrr19950004 · Cited by 41
“There is also the possibility of competition between large VLDL, and CM and large CM remnants for a common saturable lipolytic pathway during the postprandial phase (Brunzell et al. 1973) when TG levels can be increased as much as three-fold over baseline values for a period of several hours.”
BackgroundMilk and plasma lipid composition in a lactating patient with type I hyperlipoproteinemia
Steiner, G. A., Myher, J. J., & Kuksis, A. (1985) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/41.1.121 · Cited by 34
“culating triglyceride and limits the rate of catabolism of triglyceride-rich lipoproteins (2, 3).”
BackgroundStern, M. P., Haskell, W. L., Wood, P. D., Osann, K., King, A. B., & Farquhar, J. W. (1975) · Journal of Chronic Diseases · doi:10.1016/0021-9681(75)90075-2 · Cited by 34
Serum pseudocholinesterase and ceruloplasmin in various types of hyperlipoproteinemia
Cucuianu, M., Popescu, T. A., Opincaru, A., & Hărăguş, S. (1975) · Clinica Chimica Acta · doi:10.1016/0009-8981(75)90213-2 · Cited by 34
Burnett, J. R., Barrett, P. H. R., Vicini, P., Miller, D. B., Telford, D. E., Kleinstiver, S. J., & Huff, M. W. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.12.1906 · Cited by 35
“The major findings were thatatorvastatin treatment (1) significantly decreased fasting cholesterol, triglyceride, and VLDL triglyceride concentrations in plasma; (2) decreased the 0- to 12-hour TRL RP AUC; (3) increased TRL RP FCR; and (4) decreased the percent conversion from the rapid-turnover plasma compartment to…”
BackgroundInfluentialIntestinally‐derived lipoproteins: Metabolism and clinical significance
Chen, Y. I., & Reaven, G. M. (1991) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610070308 · Cited by 44
Exercise and Dietary-Mediated Reductions in Postprandial Lipemia
Plaisance, E. P., & Fisher, G. (2014) · Journal of Nutrition and Metabolism · doi:10.1155/2014/902065 · Cited by 38
“Reductions in vocational physical activity and the availability and consumption of energy-dense foods are often cited as primary culprits of the rising incidence of obesity observed throughout the world [1–6].”
BackgroundComplex effects of inhibiting hepatic apolipoprotein B100 synthesis in humans
Reyes‐Soffer, G., Moon, B. C., Hernández‐Ono, A., Dionizovik-Dimanovski, M., Jimenez, J., Obunike, J. C., Thomas, T. A., Ngai, C. I., Fontanez, N., Donovan, D. S., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad2195 · Cited by 38
“Our finding of increased FCRs for VLDL TG in the absence of increases in postheparin LpL and HL activities points to previous studies showing increased efficiency of LpL-mediated lipolysis of larger and more TGenriched particles (35).”
ResultInfluence of Aging and Menopause on Postprandial Lipoprotein Responses in Healthy Adult Women
Nabeno, Y., Fukuchi, Y., Matsutani, Y., & Naito, M. (2007) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.14.142 · Cited by 37
Bysted, A., Hølmer, G., Lund, P., Sandström, B., & Tholstrup, T. (2004) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602028 · Cited by 37
“…contribute to the postprandial responses (Cohn et al, 1988, 1989; Potts et al, 1991), compete for hydrolysis by lipoprotein lipase (LPL) as well as the hepatic receptor mediated removal of remnants from plasma (Brunzell et al, 1973; Chen & Reaven, 1991; Schneeman et al, 1993; Karpe & Hultin, 1995).”
BackgroundApolipoprotein A-I Deficiency: Biochemical and Metabolic Characteristics
Ng, D. S., Vézina, C., Wolever, T., Kuksis, A., Hegele, R. A., & Connelly, P. W. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.12.2157 · Cited by 35
Semenkovich, C. F., Goldberg, A. C., & Goldberg, I. J. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00037-7 · Cited by 37
Arky, R. A., & McCully, K. S. (1975) · New England Journal of Medicine · doi:10.1056/nejm197501022920108 · Cited by 32
Effects of fish oils on lipid variables and platelet function indices
Malle, E., & Kostner, G. M. (1993) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/0952-3278(93)90074-7 · Cited by 35
Nilsson, Å. (1977) · Biochemical Journal · doi:10.1042/bj1620367 · Cited by 32
Ensling, M., Steinmann, W. C., & Whaley‐Connell, A. T. (2011) · Cardiorenal Medicine · doi:10.1159/000322886 · Cited by 32
“Chylomicrons and endogenous TG-rich VLDL are mixed in blood and compete for LPL for TG removal. LPL-mediated removal of TG particles is limited because it is dependent on a saturation mechanism [”
BackgroundSantos, R. D., Ventura, L. I., Spósito, A. C., Schreiber, R., Ramires, J. A., & Maranhão, R. C. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00274-1 · Cited by 31
Dallongeville, J., Boulet, L., Davignon, J., & Lussier‐Cacan, S. (1991) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.11.4.864 · Cited by 34
Nolting, P. R. W. D. S., Twickler, M., Dallinga‐Thie, G. M., Buirma, R. J. A., Hutten, B. A., & Kastelein, J. J. P. (2002) · Circulation · doi:10.1161/01.cir.0000025586.89221.4b · Cited by 33
The postprandial situation as a pro-inflammatory condition
de Vries, M. A., Klop, B., Eskes, S. A., van der Loos, T. L. J. M., Klessens‐Godfroy, F. J. M., Wiebolt, J., Janssen, H. W., Westerman, E. M., & Cabezas, M. C. (2014) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2014.02.007 · Cited by 35
Ginsberg, H. N., & Tuck, C. H. (2001) · Current Diabetes Reports · doi:10.1007/s11892-001-0017-7 · Cited by 34
Yamamoto, M., Morita, S., Kumon, M., Kawabe, M., Nishitsuji, K., Saito, H., Vertut‐Doï, A., Nakano, M., & Handa, T. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(03)00058-1 · Cited by 35
Investigation and management of hypertriglyceridaemia
Ferns, G. A., Keti, V., & Griffin, B. A. (2008) · Journal of Clinical Pathology · doi:10.1136/jcp.2008.055756 · Cited by 40
Intravenous fat tolerance Correlation with very low density lipoprotein apoprotein b kinetics in man
Nicoll, A., Sigurdsson, G. T., Marsh, A. R., & Lewis, B. (1977) · Atherosclerosis · doi:10.1016/0021-9150(77)90135-6 · Cited by 30
Acute Effects of Exercise and Calorie Restriction on Triglyceride Metabolism in Women
Bellou, E., Siopi, A., Galani, M., Maraki, M. I., Tsekouras, Y. E., Panagiotakos, D. B., Kavouras, S. A., Magkos, F., & Sidossis, L. S. (2013) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e318278183e · Cited by 39
“Given that the mechanisms of TG removal from the circulation are saturable (5) and that the stimulatory effect of exercise on VLDL-TG clearance appears to level off (20), it is possible that exercise has lesser of an effect on VLDL-TG plasma clearance rate in women (~20%, present study) than in men (~40%, (26, 40)) be…”
BackgroundThe Effect of Lean Fish Consumption on Triglyceride Levels
Leaf, D. A., & Hatcher, L. F. (2009) · The Physician and Sportsmedicine · doi:10.3810/psm.2009.04.1681 · Cited by 36
Hypertriglyceridemia: Impact and Treatment
Goldberg, I. J. (2009) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2008.11.005 · Cited by 31
Intravenous Glucose Acutely Stimulates Intestinal Lipoprotein Secretion in Healthy Humans
Xiao, C., Dash, S., Morgantini, C., & Lewis, G. F. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.307044 · Cited by 33
Lundahl, B., Hamsten, A., & Karpe, F. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq0202.102876 · Cited by 32
Patsch, W., & Gotto, A. M. (1995) · Advances in pharmacology · doi:10.1016/s1054-3589(08)61018-2 · Cited by 31
Measurement of human chylomicron triglyceride clearance with a labeled commercial lipid emulsion
Park, Y., Damron, B. D., Miles, J. M., & Harris, W. S. (2001) · Lipids · doi:10.1007/s11745-001-0696-6 · Cited by 28
“Since LpL is saturable, one would expect a prolongation of half-life at higher TG concentration (28, 29 ).”
BackgroundCortner, J. A., Le, N., Coates, P. M., Bennett, M. J., & CRYER, D. R. (1992) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1992.tb01821.x · Cited by 28
Nakandakare, E. R., Lottenberg, S. A., Oliveira, H. C. F., Bertolami, M. C., Vasconcelos, K. S., Sperotto, G., & Quintão, E. C. R. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40120-8 · Cited by 28
Therapeutic Effects of Fibrates in Postprandial Lipemia
Kolovou, G. D., Kostakou, P. M., Anagnostopoulou, K. K., & Cokkinos, D. V. (2008) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200808040-00004 · Cited by 29
Lipemia pós-prandial: influência do envelhecimento
Issa, J. S., Diament, J., & Forti, N. A. (2005) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2005001400004 · Cited by 35
Fat Metabolism in Injury and Stress
Wiener, M., Rothkopf, M. M., Rothkopf, G., & ASKANAZI, J. (1987) · Critical Care Clinics · doi:10.1016/s0749-0704(18)30560-8 · Cited by 27
Mangat, R., Warnakula, S., Borthwick, F., Hassanali, Z., Uwiera, R. R. E., Russell, J. C., Cheeseman, C. I., Vine, D. F., & Proctor, S. D. (2012) · Journal of the American Heart Association · doi:10.1161/jaha.112.003434 · Cited by 30
Diagnostic evaluation of acute pancreatitis in two patients with hypertriglyceridemia
Okura, Y. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i24.3691 · Cited by 26
Exercise, lipoproteins, and coronary artery disease.
Krauss, R. M. (1989) · Circulation · doi:10.1161/01.cir.79.5.1143 · Cited by 26
Hormone replacement therapy enhances postprandial lipid metabolism in postmenopausal women
Weintraub, M. S., Grosskopf, I., Charach, G., Eckstein, N., & Rubinstein, A. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90137-3 · Cited by 28
Chylomicrons from patients with Type V hyperlipoproteinemia inhibit platelet function
Aviram, M., Furman, B., & Brook, J. G. (1985) · Atherosclerosis · doi:10.1016/0021-9150(85)90016-4 · Cited by 27
Cryer, A., Kirtland, J., Jones, H. M., & GURR, M. I. (1978) · Biochemical Journal · doi:10.1042/bj1700169 · Cited by 26
Chylomicronemia Syndrome: Very Severe Hypertriglyceridemia and Acute Pancreatitis
Wierzbicki, A. S. (2018) · Endocrine and Metabolic Medical Emergencies · doi:10.1002/9781119374800.ch44 · Cited by 28
Koichi, Y., Shinichiro, S., Zhang, Y., Hernández‐Ono, A., & Ginsberg, H. N. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m600524-jlr200 · Cited by 25
“These findings, indicating higher TG secretion but comparable apoB secretion between TAG- and DAGinfused groups, suggested that the livers of mice infused with DAG secreted larger VLDLs than the livers of mice infused with TAG.”
BackgroundInfluentialDeterminants of postprandial lipemia in obese women
Vansant, G. A. A. M., Mertens, A. C., & Muls, E. (1999) · International Journal of Obesity · doi:10.1038/sj.ijo.0800790 · Cited by 28
Dual Defect in Metabolism of Very-Low-Density Lipoprotein Triglycerides
Kesäniemi, Y. A. (1984) · JAMA · doi:10.1001/jama.251.19.2542 · Cited by 25
Lipid metabolism in pregnancy. VII. Kinetics of chylomicron triglyceride removal in fed pregnant rat
HUMPHREY, J., Childs, M. T., Montes, A., & Knopp, R. H. (1980) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1980.239.1.e81 · Cited by 34
Hazzard, W. R., & Bierman, E. L. (1975) · Metabolism · doi:10.1016/0026-0495(75)90128-6 · Cited by 26
Self-citationLPS Inhibits Fatty Acid Absorption in Enterocytes through TNF-α Secreted by Macrophages
Liu, H., Kai, L., Du, H., Wang, X., & Wang, Y. (2019) · Cells · doi:10.3390/cells8121626 · Cited by 25
“Once excessive FAs are absorbed, chylomicronemia clearly appears in the blood [25].”
BackgroundShimizu‐Albergine, M., Basu, D., Kanter, J. E., Kramer, F., Kothari, V., Barnhart, S., Thornock, C., Mullick, A. E., Clouet-Foraison, N., Vaisar, T., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci153285 · Cited by 31
“It should be noted, however, that very high TG levels saturate LPL-dependent lipolysis of TRLs in humans (58).”
BackgroundSaito, H., Kato, M., Yoshida, A., & Naito, M. (2014) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.22681 · Cited by 25
Jensen, J., Bysted, A., Dawids, S. G., Hermansen, K., & Hølmer, G. (1999) · British Journal Of Nutrition · doi:10.1017/s0007114599001725 · Cited by 26
“34) as well as the hepatic receptor-mediated removal of remnants from plasma (Brunzell et al. 1973; Schneeman et al. 1993).”
BackgroundInfluentialMaraki, M. I., Aggelopoulou, N., Christodoulou, N., Anastasiou, C. A., Toutouza, M. G., Panagiotakos, D. B., Kavouras, S. A., Magkos, F., & Sidossis, L. S. (2011) · Obesity · doi:10.1038/oby.2010.218 · Cited by 31
Verseijden, C., Meijssen, S., & Cabezas, M. C. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032171 · Cited by 25
Green, M. H., Massaro, E. R., & Green, J. B. (1984) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/40.1.82 · Cited by 23
“Thus, injected chylomicrons were competing in the catabolic processes with both postprandial VLDL and chylomicrons ( 16 ).”
BackgroundDyslipoproteinemia (a remnant lipoprotein disease) in uremic patients on hemodialysis
Minamisono, T., Wada, M., Akamatsu, A., Mitsuhisa, O., Yoji, H., Takao, M., Asagami, C., Naito, H. K., Nakamoto, S., Lewis, L. A., et al. (1978) · Clinica Chimica Acta · doi:10.1016/0009-8981(78)90490-4 · Cited by 23
Effect of phenformin on lipid transport in hypertriglyceridemia
Stout, R. W., Brunzell, J. D., Porte, D., & Bierman, E. L. (1974) · Metabolism · doi:10.1016/0026-0495(74)90115-2 · Cited by 23
Self-citation
Metadata
- Authors
- Brunzell, J. D., Hazzard, W. R., Porte, D., & Bierman, E. L.
- Affiliations
- United States Department of Veterans Affairs (US)
- ORCID
- Brunzell, John D.
- Venue
- Journal of Clinical Investigation
- Published
- 1973-07-01
- Volume
- 52
- Issue
- 7
- Pages
- 1578-1585
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC302428
- OpenAlex
- W2077829695
- Cited by
- 484
- References
- 25
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 5 · 2023: 6 · 2022: 5 · 2021: 8 · 2020: 8 · 2019: 11 · 2018: 6 · 2017: 3 · 2016: 9 · 2015: 9 · 2014: 12 · 2013: 8 · 2012: 6
- FWCI
- 15.66
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- VLDL, triglyceride-rich lipoproteins, lipoprotein lipase, Michaelis-Menten kinetics, carbohydrate intake, dietary fat, heparin infusion, lipolysis
- MeSH terms
- Adult, Chylomicrons, Dietary Carbohydrates, Dietary Fats, Female, Heparin, Humans, Hydrolysis, Hyperlipidemias, Lipoproteins, Lipoproteins, VLDL, Male, Middle Aged, Triglycerides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.